TNF Pharmaceuticals's total assets for Q1 2025 were $18.78M, a decrease of -12.33% from the previous quarter. TNFA total liabilities were $4.94M for the fiscal quarter, a -26.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.